Download PDF
Thromb Haemost 2008; 99(04): 789-790
DOI: 10.1160/TH07-12-0749
Letters to the Editor
Schattauer GmbH

Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels

Giovanna Marchetti
1   Department of Biochemistry and Molecular Biology, Ferrara University, Ferrara, Italy
,
Barbara Lunghi
1   Department of Biochemistry and Molecular Biology, Ferrara University, Ferrara, Italy
,
Gianni Mazzoni
1   Department of Biochemistry and Molecular Biology, Ferrara University, Ferrara, Italy
,
Michela Cini
2   Department of Angiology, Unità Ricerca Clinica sulla Trombofilia "Marino Golinelli", University Hospital S.Orsola-Malpighi, Bologna, Italy
,
Cristina Legnani
2   Department of Angiology, Unità Ricerca Clinica sulla Trombofilia "Marino Golinelli", University Hospital S.Orsola-Malpighi, Bologna, Italy
,
Francesco Bernardi
1   Department of Biochemistry and Molecular Biology, Ferrara University, Ferrara, Italy
› Author AffiliationsFinancial support: This work was supported by MIUR-COFIN, FAR and Comitato Sostenitori ARTGEA.
Further Information

Publication History

Received: 21 December 2007

Accepted after major revision: 27 February 2008

Publication Date:
25 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Meijers JCM, Tekelenburg WLH, Bouma BN. et al. High levels of factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
    CrossrefPubMedGoogle Scholar
  • 2 Yang DT, Flanders MM, Kim H. et al. Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events. Am J Clin Pathol 2006; 126: 411-415.
    CrossrefPubMedGoogle Scholar
  • 3 Seligsohn U. Factor XI in haemostasis and thrombosis: past, present and future. Thromb Haemost 2007; 98: 84-89.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Gerdes VE, Kraaijenhagen RA, Vogels EW. et al. Factor XI gene analysis in thrombophilia and factor XI deficiency. J Thromb Haemost 2004; 2: 1015-1017.
    CrossrefPubMedGoogle Scholar
  • 5 Mitchell MJ, Dai L, Clarke JB. et al. Characterisation of five factor XI mutations. Thromb Haemost 2007; 97: 884-889.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Hill M, McLeod F, Franks H. et al. Genetic analysis in FXI deficiency: six novel mutations and the use of a polymerase chain reaction-based test to define a whole gene deletion. Br J Haematol 2005; 129: 825-829.
    CrossrefPubMedGoogle Scholar
  • 7 Knauer DJ, Majumdar D, Fong PC. et al. Serpin regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor. J Biol Chem 2000; 275: 37340-37346.
    CrossrefPubMedGoogle Scholar
  • 8 Morange PE, Tregouet DA, Frere C. et al. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort. Br J Haematol 2005; 128: 91-99.
    CrossrefPubMedGoogle Scholar
  • 9 Tirado I, Mateo J, Soria JM. et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 2005; 93: 468-474.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Marchetti G, Lunghi B, Legnani C. et al. Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women. Haematol 2006; 91: 1261-1263.
    PubMedGoogle Scholar
  • 11 Glaser C, Schulz S, Handschug K. et al. Genetic and functional characteristics of the human in vivo LRP1/A2MR receptor suggested as a risk marker for Alzheimer’s disease and other complex (degenerative) diseases. Neurosci Res 2004; 50: 85-101.
    CrossrefPubMedGoogle Scholar